Shockwave Medical Appoints General Counsel

Shockwave Medical Inc., a developer and commercializer of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, has appointed Hajime Tada as general counsel.
 
From 2017 to 2019, Tada was general counsel and corporate secretary at LakePharma Inc., a contract research organization specializing in biologics services and technology. Prior to LakePharma, Tada spent 16 years with Agilent Technologies, where he worked his way from corporate counsel to director of Litigation, vice president and deputy general counsel, and ultimately acting general counsel. During his time at Agilent, Tada worked with the company on a range of activities that spanned the globe and across subject matters, including corporate governance, acquisitions and divestitures, compliance, sales support, regulatory, intellectual property strategy and litigation.
 
“We are pleased to welcome Haj as our new general counsel,” said Doug Godshall, president and CEO of Shockwave Medical. “His extensive experience across the spectrum of legal specialties makes Haj an exceptional addition to the team that will enable us to work more effectively and augment our growth trajectory.”
 
Tada earned a bachelor of arts degree in political science from Yale University and a juris doctor from the New York University School of Law.
 
Shockwave Medical develops and commercializes products intended to transform the way calcified cardiovascular disease is treated by establishing a new standard of care with Intravascular Lithotripsy (IVL). The company’s differentiated and proprietary IVL approach to calcium modification uses sonic pressure waves to safely and effectively fracture problematic calcium throughout the cardiovascular system in a wide and growing number of applications.